Mark Gonzalez

A birth defects lawsuit could be an option for mothers, who took the anticonvulsant Topamax within the last 15 years and delivered infants with birth defects, to seek compensation. A Johnson & Johnson subsidiary, Ortho-McNeil, first marketed Topamax in 1996 after it was approved by the US Food and Drug Administration (FDA) for the therapy for epilepsy.

Birth defects are said to be essentially the most serious side effect identified by far among the many reported Topamax side effects. Ortho-Mcneil, a Johnson & Johnson (J&J) subsidiary, created Topamax for the treatment of epilepsy and protection against certain types of migraine headaches.

Mothers who take Topamax while pregnant are raising the risk of their babies in developing birth defects especially oral clefts early in the first trimester, according to recent studies. Hyperammonemia is another Topamax side effect; however, the birth defects remain to be the most considerable side effect ever discovered by experts.

Ortho-McNeil and its mother company Johnson & Johnson should expect a rise on Topamax lawsuits after affected families are urged not to let the anticonvulsant producer get away with not issuing an early warning concerning the birth defects linked to the medication.

The US Food and Drug Administration (FDA) is asking Topamax maker Ortho-McNeil, a part of Johnson & Johnson to increase the warning label on the anticonvulsant's packing to include birth defects as one of its potential risks.

The U.S. Food and Drug Administration (FDA) has prompted all doctors to ponder first all the advantages and problems involved in Topamax medication before recommending the antiepileptic drug to all women of childbearing age in view of all the critical side effects connected to it.

In the Nineteenth century, both anticonvulsants and epilepsy drugs already existed with epilepsy afflicting human beings since the dawn of our species and recognized in the earliest medical writings, while the introduction of bromides in 1857 started the era of anticonvulsant drugs.

The documented new study which shows successful operation for treating epilepsy is welcome news after several recent studies linking Topamax with birth defects cropped up. A Topamax lawsuit remains to be available for mothers who took Topamax in their pregnant state and gave birth to babies with deformities, while there is still no reported case filed against Ortho-McNeil, a subsidiary of Johnson & Johnson, which manufactured Topamax.

Despite a quantity of side effects linked with Topamax, this anticonvulsant manufactured by Ortho-McNeil, a subsidiary of Johnson & Johnson; is one of the most prescribed treatments for epileptic seizures and prevention of some types of headaches. With birth defects, one of the most serious Topamax side effect to date, discovery of side effects associated with it has not stopped.

No matter whether a first-timer mother or not, would you make a decision that would be best for your wellbeing but would put your baby liable to birth defects or would you choose otherwise by putting your baby's health before yours?